0001209191-15-052034.txt : 20150610
0001209191-15-052034.hdr.sgml : 20150610
20150610185136
ACCESSION NUMBER: 0001209191-15-052034
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150610
FILED AS OF DATE: 20150610
DATE AS OF CHANGE: 20150610
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axovant Sciences Ltd.
CENTRAL INDEX KEY: 0001636050
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-532-8833
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
FORMER COMPANY:
FORMER CONFORMED NAME: Axovant Sciences, Inc.
DATE OF NAME CHANGE: 20150324
FORMER COMPANY:
FORMER CONFORMED NAME: Roivant Neurosciences Ltd.
DATE OF NAME CHANGE: 20150309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oren Dan
CENTRAL INDEX KEY: 0001636701
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37418
FILM NUMBER: 15924479
MAIL ADDRESS:
STREET 1: 1 DEXCEL STREET
CITY: OR AKIVA
STATE: L3
ZIP: 30600000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dexxon Holdings Ltd.
CENTRAL INDEX KEY: 0001636684
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37418
FILM NUMBER: 15924480
BUSINESS ADDRESS:
STREET 1: 1 DEXCEL STREET
CITY: OR AKIVA
STATE: L3
ZIP: 30600000
BUSINESS PHONE: 972-4-636404
MAIL ADDRESS:
STREET 1: 1 DEXCEL STREET
CITY: OR AKIVA
STATE: L3
ZIP: 30600000
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2015-06-10
0
0001636050
Axovant Sciences Ltd.
AXON
0001636684
Dexxon Holdings Ltd.
1 DEXCEL STREET
OR AKIVA
L3
30600000
ISRAEL
0
0
1
0
0001636701
Oren Dan
1 DEXCEL STREET
OR AKIVA
L3
30600000
ISRAEL
0
0
1
0
Common Shares
75000000
I
See Footnote
Dexxon Holdings Ltd. ("Dexxon") may be deemed to have investment and voting control over the 75,000,000 common shares of Axovant Sciences Ltd. held by Roivant Sciences Ltd. ("Roivant"). Voting and dispositive decisions of Dexxon are made by its sole director, Dan Oren, and Dan Oren may also be deemed to have investment and voting control over the shares held by Roivant. The filing of this statement shall not be deemed an admission that either Dexxon or Mr. Oren is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of Dexxon and Mr. Oren expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
Dexxon Holdings Ltd.
By: Dan Oren, Director
2015-06-10
Dan Oren
2015-06-10